NIPPON CHEMIPHAR
Nippon Chemiphar manufactures, sales, import and export of ethical pharmaceuticals and diagnostic agents for healthcare business.
NIPPON CHEMIPHAR
Social Links:
Industry:
Health Care Manufacturing Pharmaceutical
Founded:
1950-06-16
Status:
Active
Contact:
81 + 3-3863-1211
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Analytics Google Universal Analytics Apache Euro Microsoft Exchange Online Office 365 Mail AJAX Libraries API
Similar Organizations
Nissui Pharmaceutical
Nissui Pharmaceutical manufactures and sells pharmaceuticals and health foods for pharmacies.
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-08-18 | Molcure | Nippon Chemiphar investment in Series C - Molcure | 800 M JPY |
| 2020-08-24 | Sustainable Medicine | Nippon Chemiphar investment in Corporate Round - Sustainable Medicine | N/A |
| 2018-12-25 | Molcure | Nippon Chemiphar investment in Series B - Molcure | 300 M JPY |
More informations about "Nippon Chemiphar"
Corporate Information | NIPPON CHEMIPHAR
Chemiphar's three business areas - Develop a distinctive generic drug business that pursues quality. - Expand business by developing innovative products based on core technologies โฆSee details»
Corporate Profile | About Chemiphar | Corporate Information
The profile of NIPPON CHEMIPHAR CO., LTD.See details»
Corporate Report 2023 - chemiphar.co.jp
Since 2000, Nippon Chemiphar has promoted a basic management strategy based on three goals: establishing a strong presence in the generics business; becoming a leader in the field โฆSee details»
NIPPON CHEMIPHAR CO., LTD. | Member Companies | Japan โฆ
This page is a NIPPON CHEMIPHAR CO., LTD. page of JPMA. Address: 2-2-3 Iwamoto-cho, Chiyoda-ku, Tokyo 101-0032. Contact: Phone๏ผ+81-3-3863-1211See details»
Nippon Chemiphar Company Description - Stock Analysis
Nov 20, 2024ย ยท Nippon Chemiphar Co., Ltd., together with its subsidiaries, engages in the manufacture, sale, import, and export of ethical pharmaceuticals and diagnostic agents in โฆSee details»
Nippon Chemiphar - Crunchbase Investor Profile & Investments
Nippon Chemiphar is a manufacturer and seller of pharmaceuticals and clinical diagnostic reagents. They also make medical, health, and beauty products. They provide products and โฆSee details»
Chemiphar and Sumitomo Dainippon Pharma Conclude โฆ
Mar 31, 2021ย ยท Nippon Chemiphar was established in 1950 and is engaged in ethical pharmaceuticals, diagnostics and healthcare-related products. The Company continues to โฆSee details»
Nippon Chemiphar Co., Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Nippon Chemiphar Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 2 news, and 100 literature, Disease Domain:Nervous System Diseases, Endocrinology and โฆSee details»
Nippon Chemiphar Company Profile - Office Locations ... - Craft
Sep 26, 2024ย ยท Nippon Chemiphar has 5 employees across 6 locations and ยฅ30.75 b in annual revenue in FY 2024. See insights on Nippon Chemiphar including office locations, competitors, โฆSee details»
Nippon Chemiphar Co Ltd, 4539:TYO summary - FT.com
Oct 31, 2024ย ยท Latest Nippon Chemiphar Co Ltd (4539:TYO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.See details»
About Chemiphar | Corporate Information | NIPPON CHEMIPHAR
NIPPON CHEMIPHAR CO., LTD. HOME : Corporate Information; About Chemiphar; Business Operations. Business OperationsSee details»
Nippon Chemiphar Co Ltd, 4539:TYO profile - FT.com - Financial โฆ
Nippon Chemiphar Co Ltd (4539:TYO) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
4539.T - | Stock Price & Latest News | Reuters
4 days agoย ยท NIPPON CHEMIPHAR CO., LTD. is a Japan-based company centered on ethical pharmaceutical products and mainly engaged in the pharmaceutical, health and beauty related โฆSee details»
IFC Supports Japanese Firm to Boost Local Production of Generic โฆ
Tokyo, Japan, May 16, 2022 โIn a bid to promote local manufacturing of pharmaceutical products in nascent markets, IFC and Nippon Chemiphar Co. Ltd., a leading Japanese โฆSee details»
NC-2600 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024ย ยท NC-2600: a P2X4 receptor antagonists Drug, Initially developed by Nippon Chemiphar Co., Ltd., Now, its global highest R&D status is Phase 1, Mechanism: P2X4 โฆSee details»
Organization: Nippon Chemiphar - Cbonds.com
Nippon Chemiphar. Information about the issuer. News and credit ratings. . Tables with accounting and financial reporting.See details»
Corporate Report 2021 - chemiphar.co.jp
Since 2000, Nippon Chemiphar has promoted a basic management strategy based on three goals: establishing a strong presence in the generics business; becoming a leader in the field โฆSee details»
Nippon Chemiphar Snaps Up Japan Rights for Tumor โฆ
Mar 25, 2020ย ยท Nippon Chemiphar will obtain exclusive rights in Japan to commercialize and manufacture Tokushima-based biotech Delta-Fly Pharmaโs investigational tumor โฆSee details»
Nippon Chemiphar Co Ltd (4539) - Investing.com Canada
Nippon Chemiphar Co., Ltd., together with its subsidiaries, engages in the manufacture, sale, import, and export of ethical pharmaceuticals and diagnostic agents in Japan and โฆSee details»
Corporate Report 2020 - chemiphar.co.jp
Since 2000, Nippon Chemiphar has promoted a basic management strategy based on three goals: establishing a strong presence in the generics business; becoming a leader in the โฆSee details»